(600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 600750 · · 12 pages · Chinese
Summary by 6ix AI
The report includes a summary of major accounting data and financial indicators, as well as non-recurring profit and loss items. The financial statements included in the report are unaudited and cover the period from the beginning to the end of the quarter.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
China Resources Jiangzhong Pharmaceutical Co., Ltd. on 6ix
Earlier from China Resources Jiangzhong Pharmaceutical
- (600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing
- (600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Receipt of Drug Registration Certificate for Peony and Licorice Decoction Granules
- Announcement on Obtaining the Proprietary Chinese Medicine Registration Certificate in Macao for Jianwei Xiaoshi Tablet
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on the Profit Distribution Plan for the First Half of 2026
Follow China Resources Jiangzhong Pharmaceutical into a list and get an email when it puts out news.
Follow China Resources Jiangzhong Pharmaceutical